LifeStance Health Group, Inc. (LFST)
USD 7.09
(-5.21%)
USD 7.09
(-5.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -16.88 Million | 52.78 Million | 9.42 Million | -8.53 Million | 17.04 Million |
| Net Income | -186.26 Million | -215.56 Million | -307.19 Million | -38.07 Million | 5.66 Million |
| Depreciation & Amortization | 80.43 Million | 69.19 Million | 54.13 Million | 31.04 Million | 6.09 Million |
| Deferred income taxes | -21.92 Million | -16.73 Million | -26.94 Million | -6.5 Million | 1.76 Million |
| Stock-based compensation | 99.38 Million | 187.43 Million | 259.43 Million | 1.45 Million | 54 Thousand |
| Change in working capital | -33.72 Million | -16.93 Million | 2.14 Million | -753 Thousand | 2.99 Million |
| Other non-cash items | 45.19 Million | 45.39 Million | 27.84 Million | 80.31 Million | 478 Thousand |
| Investing Cash Flow | -60.34 Million | -139.46 Million | -194.07 Million | -861.16 Million | -73.37 Million |
| Investments in PPE | -40.52 Million | -79.25 Million | -94.49 Million | -38.06 Million | -14.31 Million |
| Acquisitions | -19.82 Million | -60.2 Million | -99.58 Million | -823.1 Million | -59.06 Million |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 47.42 Million | 47.26 Million | 313.85 Million | 912.27 Million | 48.46 Million |
| Debt repayment | -55.09 Million | -187.76 Million | -311.39 Million | -282.07 Million | -488 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | -904 Thousand | - | -1 Million | - |
| Common Stock Issuance | - | - | 549.9 Million | 21 Million | - |
| Other Financing Activities | 102.52 Million | 235.93 Million | 75.34 Million | 610.2 Million | 48.95 Million |
| Accounts receivables | -24.17 Million | -21.66 Million | -24.21 Million | -13.3 Million | -5.75 Million |
| Accounts payables | -5.6 Million | 7.66 Million | 623 Thousand | 829 Thousand | 2.53 Million |
| Inventory | - | - | - | - | - |
| Other working capital | -3.94 Million | -2.94 Million | 25.73 Million | 11.72 Million | 6.21 Million |
| Cash at beginning of period | 108.62 Million | 148.02 Million | 18.82 Million | 3.48 Million | 11.34 Million |
| Cash at end of period | 78.82 Million | 108.62 Million | 148.02 Million | 18.82 Million | 3.48 Million |
| Capital Expenditure | -40.52 Million | -79.25 Million | -94.49 Million | -38.06 Million | -14.31 Million |
| Effect of forex changes on cash | 3.03 Million | - | - | - | - |
| Net cash flow / Change in cash | -29.79 Million | -39.4 Million | 129.2 Million | 15.34 Million | -7.86 Million |
| Free Cash Flow | -57.4 Million | -26.46 Million | -85.07 Million | -46.59 Million | 2.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.27 Million | -21.09 Million | -44.95 Million | -186.26 Million | -61.58 Million | -45.47 Million |
| Depreciation & Amortization | 18.6 Million | 22.56 Million | 22.21 Million | 80.43 Million | 19.62 Million | 19.53 Million |
| Deferred income taxes | 656 Thousand | - | -21.92 Million | -21.92 Million | -16.38 Million | -6.54 Million |
| Stock-based compensation | 24.55 Million | 20.58 Million | 20.91 Million | 99.38 Million | 21.52 Million | 33.07 Million |
| Change in working capital | 13.68 Million | -51.93 Million | 27.82 Million | -33.72 Million | -15.92 Million | -19.36 Million |
| Other non-cash items | 65.3 Million | 119.3 Million | 12.71 Million | 45.19 Million | 27.39 Million | 18.34 Million |
| Investing Cash Flow | -5.11 Million | -5.1 Million | -11.41 Million | -60.34 Million | -9.79 Million | -11.58 Million |
| Investments in PPE | -5.11 Million | -5.1 Million | -11.41 Million | -40.52 Million | -9.79 Million | -11.58 Million |
| Acquisitions | - | - | - | -19.82 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.43 Million | -2.43 Million | 30.83 Million | 47.42 Million | -1.84 Million | 23.32 Million |
| Debt repayment | -732 Thousand | -731 Thousand | -32.1 Million | -55.09 Million | -648 Thousand | -587 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -700 Thousand | -1.7 Million | 62.94 Million | 102.52 Million | -1.2 Million | 23.91 Million |
| Accounts receivables | 8.71 Million | -50.53 Million | 24.3 Million | -24.17 Million | -27.92 Million | -3.42 Million |
| Accounts payables | -1.77 Million | 4.98 Million | -1.75 Million | -5.6 Million | 1.54 Million | 71 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.74 Million | -6.38 Million | 5.26 Million | -3.94 Million | 10.45 Million | -16.01 Million |
| Cash at beginning of period | 49.45 Million | 78.82 Million | 42.6 Million | 108.62 Million | 79.6 Million | 68.29 Million |
| Cash at end of period | 86.96 Million | 49.45 Million | 78.82 Million | 78.82 Million | 42.6 Million | 79.6 Million |
| Capital Expenditure | -5.11 Million | -5.1 Million | -11.41 Million | -40.52 Million | -9.79 Million | -11.58 Million |
| Effect of forex changes on cash | - | - | - | 3.03 Million | 56.62 Million | 8.21 Million |
| Net cash flow / Change in cash | 37.51 Million | -29.37 Million | 36.21 Million | -29.79 Million | -37 Million | 11.31 Million |
| Free Cash Flow | 38.95 Million | -26.94 Million | 5.38 Million | -57.4 Million | -35.15 Million | -12.01 Million |
600511
6730
IGEN
BOXE
9127
GWA